Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

PaperCitations, authors & open-access status

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 868 citations, 2015 year and hybrid oa status.

868
Citations
2015
Year
hybrid
OA Status

Related on ScholarIQ

Amit M. Oza
Author
Mansoor Raza Mirza
Author
The Lancet Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
PARP inhibition in cancer therapy
Topic
470M+ articles · free account